CatSci is a drug development partner that provides pharmaceutical manufacturing and chemical synthesis to support small and large molecule therapeutics. The UK-based company supports both early-stage discovery and development as well as late-stage development and clinical manufacturing with process design, assessment and optimization, scale-up, and tech transfer. CatSci also applies their CMC experience to provide oligonucleotide services, including process R&D, material supply, and analytical development.
